- 07:21 PM Trading in MF units to start in 15 days: SEBI
- 07:17 PM MphasiS Q4 cons net profit up 33.9% at Rs 245 cr
- 06:59 PM Immediate supports for rupee at 46.20/46.10: Commt...
- 06:57 PM Want a green holiday, shop at night? Head to Taipe...
- 06:54 PM World oil demand growth to outpace supply in 2010
- 06:52 PM FIIs net sell Rs 68 cr in equities on Nov 23
- 06:38 PM Buy Unity Infra: target of Rs 605: India Capital M...
- 06:38 PM Godrej Group puts two brands on the block
- 06:26 PM Mkts consolidates after 2 days of strong rally: Ni...
- 06:25 PM Karvy negative on telecom sector
Zydus Cadila has received an approval from the US FDA to market Carvedilol Tablets 3.125 mg, 6.25 mg, 12.5 mg and 25 mg., in the US market. The drug falls in the Cardiovascular segment. The sales of Carvedilol Tablets in the US market as per NDC Health is estimated at USD 1.24 bn.
Gaining a significant advantage, Zydus Pharmaceuticals (USA) Inc., launched the product on the very first day after receiving approval from the USFDA.
The group now has 27 approvals since the commencement of filing process in FY 2003-04. So far, the group has filed 65 ANDAs and 55 DMFs.
Sourced From: Pressman India
|
|
Business
Business News | Economy | Earnings | BSE NSE Notices
General News
Current Affairs | Politics | World News | Sports | Entertainment
Corporate Strategy
Management | Advertising | Marketing | Legal
Personal Finance
Tax | Insurance | Credit Cards | Loans | Property | Retirement | Investment Help | Financial Planning | Fixed Income
Markets
Local Market | Global Market | Market Cues | Analysis | Expert & FII outlook | Brokerage Recomendation
Stocks
Stocks in News | Expert Advice | ADRs & GDRs | IPO
Mutual Funds
News | Advice | MF Analysis | Fund Managers Views
Lifestyle
Travel | Wellness | Technology | Auto| Books
-
Most Read
-
Most Viewed
- 10 Companies that FIIs love
- 10 companies that MF managers love
- Mitesh Thacker's top 5 picks for trade today
- Ganeshaspeaks: Market prediction for Nov 24
- Will ITC dream run continue beyond FY10?
- Den Networks slips 22% after listing at Rs 195
- Trading in MF units to start in 15 days: SEBI
- Why LyondellBasell is a goldmine for RIL
- Experts see mkts at new highs, advise sectors
- Corrections in '10 to be more aggressive, violent: JPMorgan
- Mahindra may increase car prices due to rising input costs
Source: Business Line
- Renault to continue with M&M for Logan, says Ghosn
Source: Business Line
- Market volatility poses valuation problems: IRDA
Source: Business Line
- Punjab, Haryana buck all-India rice decline trend
Source: Business Line
